Table 2.
Comparisons of FLJ10540 and osteopontin expressions between the subgroups of various clincopathological parameters
|
FLJ10540 expression |
p-valuea |
Osteopontin expression |
p-valuea | |||
|---|---|---|---|---|---|---|
|
Low |
High |
Low |
High |
|||
| (n=42) | (n=21) | (n=47) | (n=16) | |||
| Age (year), |
|
|
0.582 |
|
|
0.212 |
| < 50 |
17 |
7 |
|
20 |
4 |
|
| ≥ 50 |
25 |
14 |
|
27 |
12 |
|
| Gender |
|
|
0.838 |
|
|
1.000 |
| Male |
31 |
16 |
|
35 |
12 |
|
| Female |
11 |
5 |
|
12 |
4 |
|
| Histology |
|
|
0.856 |
|
|
0.816 |
| WHO type II |
25 |
12 |
|
28 |
9 |
|
| WHO type III |
17 |
9 |
|
19 |
7 |
|
| Tumor size |
|
|
<0.001 |
|
|
<0.001 |
| T1-T2 |
40 |
4 |
|
40 |
0 |
|
| T3-T4 |
2 |
17 |
|
3 |
16 |
|
| Nodal stage |
|
|
0.001 |
|
|
0.007 |
| N0-N1 |
34 |
7 |
|
35 |
6 |
|
| N2-N3 |
8 |
14 |
|
12 |
10 |
|
| AJCC staging |
|
|
<0.001 |
|
|
<0.001 |
| I-II |
32 |
0 |
|
32 |
0 |
|
| III-IV | 10 | 21 | 15 | 16 | ||
Abbreviations: NPC naso-pharyngeal carcinoma; WHO World Healthy Organization; AJCC American Joint Committee on Cancer.
ap-value from Chi-square or Fisher exact test. Statistically significant (p < 0.05).